1. A potent and selective inhibitor of cyclic AMP phosphodiesterase with potential cardiotonic and antithrombotic properties;Alvarez;Molec. Pharmac.,1986
2. Cyclic nucleotide phosphodiesterases: properties, activators, inhibitors, structure-activity relationships, and possible role in drug development;Amer;J. Pharmac. Sci.,1975
3. Analysis of the binding sites for the cardiotonic phosphodiesterase inhibitor [3H]-LY186126 in ventricular myocardium;Artman;Molec. Pharmac.,1989
4. Cyclic AMP turnover in response to prostaglandins in intact platelets: evidence for separate stimulatory and inhibitory prostaglandin receptors;Ashby;Sec. Mess. Phos.,1988
5. Role of high affinity cAMP phosphodiesterase activities in the response of S49 cells to agonists;Barber;Molec. Pharmac.,1987